Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al
J Eur Acad Dermatol Venereol
.
2022 Jun;36(6):e433-e435.
doi: 10.1111/jdv.17959.
Epub 2022 Feb 4.
Authors
G Avallone
1
,
S Giordano
1
,
C Astrua
1
,
M Merli
1
,
R Senetta
2
,
C Conforti
3
,
S Ribero
1
,
A V Marzano
4
5
,
P Quaglino
1
Affiliations
1
Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
2
Department of Oncology, Pathology Unit, University of Turin, Turin, Italy.
3
Dermatology Clinic, Maggiore Hospital, Trieste, Italy.
4
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
5
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
PMID:
35067994
DOI:
10.1111/jdv.17959
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Pemphigoid, Bullous* / chemically induced
Pemphigus*
Substances
COVID-19 Vaccines